Normal levels of KIF5 but reduced KLC1 levels in both Alzheimer disease and Alzheimer disease in Down syndrome: evidence suggesting defects in anterograde transport

Xu‐Qiao Chen(Chinese Academy of Sciences), William C. Mobley(University of California San Diego)
Alzheimer s Research & Therapy
March 10, 2021
10.1186/s13195-021-00796-6
Cited by 18

Related Papers

CaMKIIα and caveolin-1 cooperate to drive ATP-induced membrane delivery of the P2X3 receptor
|Journal of Molecular Cell Biology|2014|18
Retromer Proteins Reduced in Down Syndrome and the Dp16 Model: Impact of<scp><i>APP</i></scp>Dose and Preclinical Studies of a γ‐Secretase Modulator
|Annals of Neurology|2023|12
<scp>γ‐Secretase</scp> Modulator <scp>BPN15606</scp> Reduced Aβ42 and Aβ40 and Countered Alzheimer‐Related Pathologies in a Mouse Model of Down Syndrome
|Annals of Neurology|2024|12